Incyte to acquire North Carolina drug developer in deal valued at up to $1.36 billion By: Philadelphia Business Journal via Business Journals October 03, 2022 at 10:20 AM EDT The deal involving an experimental skin disorder drug includes an upfront payment of $70 million. Read More >>
